View in EDS

Characteristics of circulating KSHV-infected viroblasts during active KSHV+ multicentric Castleman disease.

Saved in:
Bibliographic Details
Title: Characteristics of circulating KSHV-infected viroblasts during active KSHV+ multicentric Castleman disease.
Authors: Martin de Frémont G; INSERM U976 HIPI, équipe INSIGHT, Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France.; Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France.; National Reference Center for Castleman disease, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France., Vanjak A; INSERM U976 HIPI, équipe INSIGHT, Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France.; Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France.; National Reference Center for Castleman disease, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France., Sbihi Z; INSERM U976 HIPI, équipe INSIGHT, Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France., Knapp S; INSERM U976 HIPI, équipe INSIGHT, Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France., Garzaro M; INSERM U976 HIPI, équipe INSIGHT, Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France.; Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France.; National Reference Center for Castleman disease, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France., Chbihi M; INSERM U976 HIPI, équipe INSIGHT, Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France., Fournier B; Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, INESRM UMR 1163, Imagine Institute, Université Paris Cité Paris, France., Poirot J; INSERM U976 HIPI, équipe INSIGHT, Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France., Dossier A; Department of Internal Medicine, Hôpital Bichat, AP-HP, Université Paris Cité, Paris, France., Silvestrini MA; INSERM U976 HIPI, équipe INSIGHT, Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France., Villemonteix J; Laboratory of Immunology, Hôpital Robert Debré, AP-HP, Université Paris Cité, Paris, France., Meignin V; Department of Pathology, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France., Galicier L; Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France.; National Reference Center for Castleman disease, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France., Bertinchamp R; Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France.; National Reference Center for Castleman disease, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France., Le Goff J; Laboratory of Virology, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France., Salmona M; Laboratory of Virology, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France., Flamarion E; Department of Internal Medicine, Hôpital Européen Georges Pompidou, AP-HP, Université Paris Cité, Paris, France., Cassius C; Department of Dermatology, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France., Lebbé C; Department of Dermatology, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France., Ronchetti AM; Department of Clinical Hematology, Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France., Latour S; Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, INESRM UMR 1163, Imagine Institute, Université Paris Cité Paris, France., Oksenhendler E; Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France.; National Reference Center for Castleman disease, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France., Carcelain G; INSERM U976 HIPI, équipe INSIGHT, Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France., Boutboul D; INSERM U976 HIPI, équipe INSIGHT, Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France.; Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France.; National Reference Center for Castleman disease, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France.
Source: Blood advances [Blood Adv] 2023 May 09; Vol. 7 (9), pp. 1682-1691.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36508281
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Characteristics of circulating KSHV-infected viroblasts during active KSHV+ multicentric Castleman disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Martin+de+Frémont+G%22">Martin de Frémont G</searchLink>; INSERM U976 HIPI, équipe INSIGHT, Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France.; Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France.; National Reference Center for Castleman disease, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Vanjak+A%22">Vanjak A</searchLink>; INSERM U976 HIPI, équipe INSIGHT, Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France.; Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France.; National Reference Center for Castleman disease, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Sbihi+Z%22">Sbihi Z</searchLink>; INSERM U976 HIPI, équipe INSIGHT, Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Knapp+S%22">Knapp S</searchLink>; INSERM U976 HIPI, équipe INSIGHT, Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Garzaro+M%22">Garzaro M</searchLink>; INSERM U976 HIPI, équipe INSIGHT, Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France.; Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France.; National Reference Center for Castleman disease, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Chbihi+M%22">Chbihi M</searchLink>; INSERM U976 HIPI, équipe INSIGHT, Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Fournier+B%22">Fournier B</searchLink>; Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, INESRM UMR 1163, Imagine Institute, Université Paris Cité Paris, France.<br /><searchLink fieldCode="AU" term="%22Poirot+J%22">Poirot J</searchLink>; INSERM U976 HIPI, équipe INSIGHT, Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Dossier+A%22">Dossier A</searchLink>; Department of Internal Medicine, Hôpital Bichat, AP-HP, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Silvestrini+MA%22">Silvestrini MA</searchLink>; INSERM U976 HIPI, équipe INSIGHT, Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Villemonteix+J%22">Villemonteix J</searchLink>; Laboratory of Immunology, Hôpital Robert Debré, AP-HP, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Meignin+V%22">Meignin V</searchLink>; Department of Pathology, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Galicier+L%22">Galicier L</searchLink>; Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France.; National Reference Center for Castleman disease, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Bertinchamp+R%22">Bertinchamp R</searchLink>; Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France.; National Reference Center for Castleman disease, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Le+Goff+J%22">Le Goff J</searchLink>; Laboratory of Virology, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Salmona+M%22">Salmona M</searchLink>; Laboratory of Virology, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Flamarion+E%22">Flamarion E</searchLink>; Department of Internal Medicine, Hôpital Européen Georges Pompidou, AP-HP, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Cassius+C%22">Cassius C</searchLink>; Department of Dermatology, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Lebbé+C%22">Lebbé C</searchLink>; Department of Dermatology, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Ronchetti+AM%22">Ronchetti AM</searchLink>; Department of Clinical Hematology, Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France.<br /><searchLink fieldCode="AU" term="%22Latour+S%22">Latour S</searchLink>; Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, INESRM UMR 1163, Imagine Institute, Université Paris Cité Paris, France.<br /><searchLink fieldCode="AU" term="%22Oksenhendler+E%22">Oksenhendler E</searchLink>; Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France.; National Reference Center for Castleman disease, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Carcelain+G%22">Carcelain G</searchLink>; INSERM U976 HIPI, équipe INSIGHT, Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Boutboul+D%22">Boutboul D</searchLink>; INSERM U976 HIPI, équipe INSIGHT, Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France.; Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France.; National Reference Center for Castleman disease, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2023 May 09; Vol. 7 (9), pp. 1682-1691.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36508281
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2022008456
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1682
    Titles:
      – TitleFull: Characteristics of circulating KSHV-infected viroblasts during active KSHV+ multicentric Castleman disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Martin de Frémont G
      – PersonEntity:
          Name:
            NameFull: Vanjak A
      – PersonEntity:
          Name:
            NameFull: Sbihi Z
      – PersonEntity:
          Name:
            NameFull: Knapp S
      – PersonEntity:
          Name:
            NameFull: Garzaro M
      – PersonEntity:
          Name:
            NameFull: Chbihi M
      – PersonEntity:
          Name:
            NameFull: Fournier B
      – PersonEntity:
          Name:
            NameFull: Poirot J
      – PersonEntity:
          Name:
            NameFull: Dossier A
      – PersonEntity:
          Name:
            NameFull: Silvestrini MA
      – PersonEntity:
          Name:
            NameFull: Villemonteix J
      – PersonEntity:
          Name:
            NameFull: Meignin V
      – PersonEntity:
          Name:
            NameFull: Galicier L
      – PersonEntity:
          Name:
            NameFull: Bertinchamp R
      – PersonEntity:
          Name:
            NameFull: Le Goff J
      – PersonEntity:
          Name:
            NameFull: Salmona M
      – PersonEntity:
          Name:
            NameFull: Flamarion E
      – PersonEntity:
          Name:
            NameFull: Cassius C
      – PersonEntity:
          Name:
            NameFull: Lebbé C
      – PersonEntity:
          Name:
            NameFull: Ronchetti AM
      – PersonEntity:
          Name:
            NameFull: Latour S
      – PersonEntity:
          Name:
            NameFull: Oksenhendler E
      – PersonEntity:
          Name:
            NameFull: Carcelain G
      – PersonEntity:
          Name:
            NameFull: Boutboul D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 05
              Text: 2023 May 09
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1